Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vera Therapeutics, Inc.CL A(VERA) | 714,000 | 684,000 | -30,000 | $25.83M | $30.23M | 9.01% | +$4.40M |
| Adma Biologics Inc | 1,510,000 | 1,360,000 | -150,000 | $16.88M | $27.19M | 8.10% | +$10.30M |
| Sarepta Therapeutics, Inc.(SRPT) | 81,900 | 170,000 | +88,100 | $12.94M | $21.23M | 6.33% | +$8.29M |
| Edwards Lifesciences Corp | 0 | 222,000 | +222,000 | $0 | $14.65M | 4.36% | +$14.65M |
| Xenon Pharmaceuticals Inc.(XENE) | 360,600 | 360,600 | 0 | $14.06M | $14.20M | 4.23% | +$137.0K |
| Zevra Therapeutics, Inc.(ZVRA) | 1,162,416 | 1,700,000 | +537,584 | $5.70M | $11.80M | 3.51% | +$6.10M |
| Intra-Cellular Therapies Inc | 193,000 | 154,000 | -39,000 | $13.22M | $11.27M | 3.36% | -$1.95M |
| Soleno Therapeutics Inc | 212,909 | 212,909 | 0 | $8.69M | $10.75M | 3.20% | +$2.06M |
| Glaukos Corporation(GKOS) | 0 | 77,000 | +77,000 | $0 | $10.03M | 2.99% | +$10.03M |
| Insmed Incorporated(INSM) | 190,000 | 130,000 | -60,000 | $12.73M | $9.49M | 2.83% | -$3.24M |
| Merit Medical Systems, Inc.(MMSI) | 0 | 85,000 | +85,000 | $0 | $8.40M | 2.50% | +$8.40M |
| Rezolute, Inc.(RZLT) | 1,700,000 | 1,700,000 | 0 | $7.31M | $8.24M | 2.46% | +$935.0K |
| Vaxcyte, Inc.(PCVX) | 0 | 72,000 | +72,000 | $0 | $8.23M | 2.45% | +$8.23M |
| Avadel Pharmaceuticals Plc | 610,000 | 610,000 | 0 | $8.58M | $8.00M | 2.38% | -$576.5K |
| Viking Therapeutics, Inc.(VKTX) | 122,000 | 126,000 | +4,000 | $6.47M | $7.98M | 2.38% | +$1.51M |
| Catalyst Pharmaceuticals Inc | 500,000 | 385,000 | -115,000 | $7.75M | $7.65M | 2.28% | -$91.2K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 429,340 | 369,126 | -60,214 | $7.56M | $7.07M | 2.10% | -$495.6K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 355,000 | +355,000 | $0 | $6.88M | 2.05% | +$6.88M |
| Savara Inc.(SVRA) | 1,575,000 | 1,575,000 | 0 | $6.35M | $6.68M | 1.99% | +$330.8K |
| iRhythm Holdings, Inc.(IRTC) | 0 | 86,000 | +86,000 | $0 | $6.38M | 1.90% | +$6.38M |
| Evolus, Inc.(EOLS) | 0 | 355,000 | +355,000 | $0 | $5.75M | 1.71% | +$5.75M |
| Establishment Labs Holdings Inc.(ESTA) | 0 | 131,000 | +131,000 | $0 | $5.67M | 1.69% | +$5.67M |
| RxSight, Inc.(RXST) | 0 | 112,000 | +112,000 | $0 | $5.54M | 1.65% | +$5.54M |
| Axsome Therapeutics, Inc.(AXSM) | 50,000 | 58,000 | +8,000 | $4.03M | $5.21M | 1.55% | +$1.19M |
| Skye Bioscience, Inc.(SKYE) | 1,350,093 | 1,315,146 | -34,947 | $10.81M | $5.14M | 1.53% | -$5.67M |
| Xtant Medical Holdings, Inc.(XTNT) | 7,415,413 | 7,415,413 | 0 | $4.67M | $5.01M | 1.49% | +$341.1K |
| Larimar Therapeutics, Inc.(LRMR) | 693,000 | 693,000 | 0 | $5.02M | $4.54M | 1.35% | -$485.1K |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 285,000 | +285,000 | $0 | $4.33M | 1.29% | +$4.33M |
| Pulmonx Corporation(LUNG) | 0 | 500,000 | +500,000 | $0 | $4.14M | 1.23% | +$4.14M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 195,000 | +195,000 | $0 | $4.02M | 1.20% | +$4.02M |
| Keros Therapeutics, Inc.(KROS) | 0 | 69,000 | +69,000 | $0 | $4.01M | 1.19% | +$4.01M |
| The RealReal, Inc.(REAL) | 1,250,238 | 1,270,000 | +19,762 | $3.99M | $3.99M | 1.19% | -$459 |
| Perspective Therapeutics, Inc.(CATX) | 191,450 | 290,000 | +98,550 | $1.91M | $3.87M | 1.15% | +$1.96M |
| Biohaven Ltd.(BHVN) | 0 | 75,000 | +75,000 | $0 | $3.75M | 1.12% | +$3.75M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 405,000 | 355,000 | -50,000 | $2.86M | $3.64M | 1.08% | +$775.4K |
| Structure Therapeutics IncADS | 0 | 70,000 | +70,000 | $0 | $3.07M | 0.92% | +$3.07M |
| Outlook Therapeutics, Inc.(OTLK) | 501,785 | 541,549 | +39,764 | $3.70M | $2.89M | 0.86% | -$811.3K |
| Vericel Corporation(VCEL) | 0 | 68,000 | +68,000 | $0 | $2.87M | 0.86% | +$2.87M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 317,000 | +317,000 | $0 | $2.82M | 0.84% | +$2.82M |
| Terns Pharmaceuticals Inc | 0 | 330,000 | +330,000 | $0 | $2.75M | 0.82% | +$2.75M |
| Ocugen, Inc.(OCGN) | 0 | 2,350,000 | +2,350,000 | $0 | $2.33M | 0.69% | +$2.33M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 115,000 | 40,000 | -75,000 | $5.06M | $2.02M | 0.60% | -$3.04M |
| Bicycle Therapeutics PlcADS | 0 | 85,000 | +85,000 | $0 | $1.92M | 0.57% | +$1.92M |
| Veru Inc.(VERU) | 2,276,692 | 2,028,534 | -248,158 | $1.92M | $1.56M | 0.46% | -$355.4K |
| AtriCure, Inc.(ATRC) | 0 | 54,000 | +54,000 | $0 | $1.51M | 0.45% | +$1.51M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 915,000 | +915,000 | $0 | $1.08M | 0.32% | +$1.08M |
| enVVeno Medical Corporation(NVNO) | 0 | 238,920 | +238,920 | $0 | $802.8K | 0.24% | +$802.8K |
| Tempest Therapeutics, Inc.(TPST) | 0 | 545,000 | +545,000 | $0 | $763.0K | 0.23% | +$763.0K |
| Promis Neurosciences Inc | 0 | 581,395 | +581,395 | $0 | $726.7K | 0.22% | +$726.7K |
| Milestone Pharmaceuticals Inc.(MIST) | 1,012,368 | 440,000 | -572,368 | $1.34M | $668.8K | 0.20% | -$667.5K |
| Karyopharm Therapeutics Inc.(KPTI) | 740,000 | 740,000 | 0 | $642.0K | $614.2K | 0.18% | -$27.8K |
| Unicycive Therapeutics Inc | 0 | 1,473,000 | +1,473,000 | $0 | $600.8K | 0.18% | +$600.8K |
| Fat Brands IncW EXP 07 16 202 | 200,000 | 200,000 | 0 | $569.0K | $499.0K | 0.15% | -$70.0K |
| Cellectar Biosciences, Inc.(CLRB) | 0 | 215,000 | +215,000 | $0 | $460.1K | 0.14% | +$460.1K |
| SRX Global Inc.(SRXH) | 0 | 133,117 | +133,117 | $0 | $278.2K | 0.08% | +$278.2K |
| Expion Energy, Inc.(XPON) | 0 | 2,057,494 | +2,057,494 | $0 | $106.4K | 0.03% | +$106.4K |
| Nexgel IncW EXP 12 01 202 | 225,000 | 225,000 | 0 | $98.3K | $91.5K | 0.03% | -$6.9K |
| Scorpius Holdings Inc | 0 | 88,291 | +88,291 | $0 | $63.6K | 0.02% | +$63.6K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 731,561 | 731,561 | 0 | $44.4K | $51.2K | 0.02% | +$6.8K |
| Onfolio Holdings, Inc.W EXP 01 02 202(ONFO) | 200,000 | 200,000 | 0 | $49.8K | $34.0K | 0.01% | -$15.8K |
| Wearable Devices LtdW EXP 09 14 202 | 1,411,600 | 1,411,600 | 0 | $70.0K | $28.1K | 0.01% | -$41.9K |
| Mobix Labs, Inc.W EXP 99 99 999(MOBX) | 150,000 | 150,000 | 0 | $26.8K | $22.3K | 0.01% | -$4.5K |
| Cingulate Inc.W EXP 12 10 202(CING) | 270,000 | 270,000 | 0 | $2.9K | $18.7K | 0.01% | +$15.8K |
| Nektar Therapeutics(NKTR) | 0 | 11,419 | +11,419 | $0 | $14.8K | 0.00% | +$14.8K |
| Nexalin Technology IncW EXP 99 99 999 | 105,000 | 105,000 | 0 | $35.7K | $8.4K | 0.00% | -$27.3K |
| BNB Standard CorporationW EXP 02 11 202(BNC) | 250,000 | 250,000 | 0 | $3.8K | $6.3K | 0.00% | +$2.5K |
| VSee Health, Inc.W EXP 99 99 999(VSEE) | 150,000 | 150,000 | 0 | $32.5K | $6.0K | 0.00% | -$26.5K |
| Bitcoin Depot IncW EXP 06 30 202 | 50,000 | 50,000 | 0 | $2.4K | $2.5K | 0.00% | +$130 |
| Nexera Technologies LtdW EXP 99 99 999(NEXR) | 68,681 | 68,681 | 0 | $2.2K | $2.4K | 0.00% | +$247 |
| Nls Pharmaceutics LtdW EXP 02 02 202 | 200,000 | 200,000 | 0 | $6.9K | $2.3K | 0.00% | -$4.6K |
| Cycurion, Inc.W EXP 99 99 999(CYCU) | 100,000 | 100,000 | 0 | $3.7K | $2.2K | 0.00% | -$1.5K |
| CDT Equity Inc.W EXP 09 22 202(CDT) | 100,000 | 100,000 | 0 | $1.6K | $1.6K | 0.00% | +$45 |
| Coliseum Acquisition CorpW EXP 08 22 202 | 28,333 | 28,333 | 0 | $1.4K | $1.4K | 0.00% | $0 |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 82,233 | 82,233 | 0 | $1.4K | $1.0K | 0.00% | -$321 |
| Tc Biopharm Holdings PlcW EXP 02 10 202 | 18,823 | 18,823 | 0 | $235 | $343 | 0.00% | +$108 |
| Achieve Life Sciences Inc | 216,310 | 0 | -216,310 | $1.02M | $0 | — | -$1.02M |
| Alimera Sciences Inc | 2,150,000 | 0 | -2,150,000 | $11.95M | $0 | — | -$11.95M |
| Allurion Technologies Inc | 969,840 | 0 | -969,840 | $967.5K | $0 | — | -$967.5K |
| Applied Dna Sciences Inc | 86,152 | 0 | -86,152 | $35.2K | $0 | — | -$35.2K |
| Aprea Therapeutics, Inc.(APRE) | 137,197 | 0 | -137,197 | $558.4K | $0 | — | -$558.4K |
| argenx SEADR(ARGX) | 23,000 | 0 | -23,000 | $9.89M | $0 | — | -$9.89M |
| Ascendis Pharma A/SADR(ASND) | 50,000 | 0 | -50,000 | $6.82M | $0 | — | -$6.82M |
| BioVie Inc.CL A(BIVI) | 1,982,341 | 0 | -1,982,341 | $793.9K | $0 | — | -$793.9K |
| Boundless Bio, Inc.(BOLD) | 83,149 | 0 | -83,149 | $321.8K | $0 | — | -$321.8K |
| Cemtrex Inc | 339,961 | 0 | -339,961 | $74.8K | $0 | — | -$74.8K |
| Context Therapeutics Inc.(CNTX) | 360,001 | 0 | -360,001 | $721.8K | $0 | — | -$721.8K |
| Cybin D/B/A Helus Pharma(HELP) | 13,953,488 | 0 | -13,953,488 | $3.78M | $0 | — | -$3.78M |
| Evoke Pharma Inc | 692,440 | 0 | -692,440 | $366.3K | $0 | — | -$366.3K |
| Intelligent Bio Solutions In | 83,906 | 0 | -83,906 | $161.1K | $0 | — | -$161.1K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 121,986 | 0 | -121,986 | $204.9K | $0 | — | -$204.9K |
| Perfect Moment Ltd. Common Stock(PMNT) | 62,835 | 0 | -62,835 | $135.1K | $0 | — | -$135.1K |
| Quoin Pharmaceuticals LtdADS | 103,127 | 0 | -103,127 | $59.8K | $0 | — | -$59.8K |
| Selina Hospitality PlcW EXP 10 27 202 | 101,439 | 0 | -101,439 | $1.1K | $0 | — | -$1.1K |
| Spruce Biosciences Inc | 811,167 | 0 | -811,167 | $419.9K | $0 | — | -$419.9K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 70,000 | 0 | -70,000 | $2.88M | $0 | — | -$2.88M |